Immune Hemolytic Anemias (IHAs)
– Premature destruction of RBCs by the immune process mediated by antibody and/or complement.
– Presence and severity of anemia depend on:
▪ The severity of hemolysis.
▪ The ability of BM to compensate for RBC losses.
– Initial confirmation of immune mechanism
▪ Demonstration of attachment of Ab or complement to the patient's RBC.
– Diagnosis of anemia:
▪ Reduced Hb and Hct, increased reticulocytes and/or unbound bilirubin
▪ Reduced haptoglobin
Classification of IHAs
• Based on stimulus for antibody production
– Autoimmune hemolytic anemia.
– Drug-induced hemolytic anemia.
– Alloimmune hemolytic anemia.
• The determination process is important because each type requires specific treatment.
Autoimmune hemolytic anemia (AIHA)
– Shortened RBC survival
– Due to the production of autoantibodies against RBC antigens
– Ab-induced reactions include
▪ Sensitization, agglutination, hemolysis.
– Further classified
▪ Warm-antibody autoimmune HA (WAIHA)
▪ Cold-antibody AIHA (cold agglutinin disease/CAD)
▪ Mixed-type AIHA (both warm-reacting and cold-reacting autoantibodies).
Drug-induced hemolytic anemia
– Drugs bind to the RBC membrane or change it.
– Classification based on the patient's red blood cell and drug response in the vitro test system
▪ Drug-dependent
▪ Drug-independent.
Alloimmune hemolytic anemia
– Antibody (Ab) produced to RBC antigen (Ag) that individual lacks
▪ Do not react with individual's own RBCs
▪ HDFN-mother creates Abs against Ags on fetal RBCs
▪ Transfusion reactions when the recipient makes Abs to Ags on transfused (donor cells).
Characteristics of Agglutinin in Hemolytic Anemia
|
Warm-Reacting
Antibodies
|
Cold-Reacting
Antibodies
|
Immunoglobulin
class
|
IgG
IgM (rare)
IgA (Usually
with IgG)
|
IgM
IgG (PCH only)
|
Optimal
reactivity
|
37oC
|
<30oC,
usually <10oC
|
Mechanism of
Hemolysis
|
-Extravascular
Attachment of membrane-bound IgG or C3b to macrophages receptors
|
-Intravascular,
complement-mediated lysis.
-Extravascular,
Attachment of membrane-bound IgG or C3b to macrophages receptors
|
Specificity
|
Usually broad
Specificity anti-Rh
|
-Usually
autoanti-I
-Occasionally
autoanti-i
-PCH: autoanti-P
|
Sites and Factors that Affect Hemolysis
Intravascular or extravascular hemolysis
– Depends on:
▪ Class of Ab
▪ Ability to fully activate the complement cascade.
– Extravascular hemolysis
▪ Most common
▪ RBC sensitized with Ab or complement
▪ Sensitized cells phagocytized by macrophages in the spleen or liver.
– Intravascular hemolysis
▪ Complement cascade activated C9 (MAC) leads to RBC lysis.
Immune-mediated extravascular hemolysis. Erythrocytes sensitized with antibody or complement (C3b) attach to macrophages via specific cell receptors for these immune proteins.
Factors affecting the rate of hemolysis in IHAs
Mechanisms of Hemolysis
• Based on the presence of IgM, IgG, and/or complement in RBC
• Three types:
– IgG-mediated
– Complement-mediated
– IgM-mediated
IgG-Mediated Hemolysis
• IgG is attached to the RBC membrane Ags through the Fab region.
• Fc receptors
– FcγR-I, -II, -III on splenic macrophages
– Bind to the Fc part of Ab connected to RBC
– Macrophage pits the Ag/Ab complex
•Fc receptors
– Damages RBC membrane
– RBC membrane reseals itself
– The spleen repeatedly passes —continues to lose membrane, forms spherocyte
▪ Phagocytized by splenic macrophages.
• Ab-sensitized RBCs can be entirely engulfed by:
– Macrophages
– PMN (FcγR-I, -III)
• NK cells (FcγR-III)— leads to ADCC (Ab dependent cell-mediated cytotoxicity)
• Spleen
– Lightly opsonized cells more efficiently removed
• Liver
– Removes heavily sensitized cells
• Splenomegaly is common.
Complement-Mediated Hemolysis
Role of complement
– Sensitization
▪ The only part of the complement cascade is activated and deposited on the RBC membrane
– Lysis of RBCs
▪ The entire complement system is activated and deposited on the RBC membrane.
• Initiation of complement activation
– Classic, alternate, lectin mechanisms
• Classic pathway
– Initiated by Ag/Ab reaction
▪ IgM
–Activates complement more efficiently
–Only requires one IgM molecule
▪ IgG (IgG1 and IgG3; occasional IgG2)
–Activation requires two IgG molecules
• Cascade initiated
–C1 sticks to the Fc region of IgG or IgM.
– Activates C4, C2, C3
– Activates the terminal components C5 to C9
▪ Membrane attack complex (MAC)
–Lytic attack to RBC membrane
–Intravascular hemolysis when complement activation C1 to C9 is complete.
• Cascade initiated
– Activations through C3
▪ RBC sensitized with C3b
– Macrophages completely or partially engulf the C3b receptor
▪ C3b on RBC divided by plasma C3b inactivator
▪ C3c dissociates from the membrane.
▪ C3d no receptors on macrophages
–Normal RBC survival
IgM-Mediated Hemolysis
• Macrophages lack receptors for the Fc portion of IgM.
– IgM is an efficient activator of complement
▪ Intravascular
–Complement activation through C9 and RBC hemolyzes.
• Macrophages lack receptors for the Fc portion of IgM.
– IgM is an efficient activator of complement.
▪ Extravascular
–Activation incomplete
–C3b coats RBCs and sensitized cells destroyed extravascularly through CR1 and CR3 receptors on macrophages.
– IgM is able to agglutinate cells in addition to activating complement.
Laboratory ID of Sensitized RBCs
• Two agglutination techniques
– Saline—detects IgM antibodies
– AHG test—detects IgG and/or complement
▪ Direct AHG (DAT)
–Detects RBCs coated in vivo
– Needed to differentiate AIHA from other types of HA
• Two agglutination techniques
– AHG test—detects IgG and/or complement
▪ Indirect AHG (IAT)
–Detects antigens in plasma or serum (in vitro)
– Specify alloimmunization or free autoAbs in the patient's serum.
• Negative DAT in AIHA
– Can result from
▪ Insufficient number of IgG molecules on RBCs
▪ Autoantibodies of IgA or IgM class
▪ Autoantibodies with low affinity for RBCs
• Negative DAT in AIHA
– Newer techniques more sensitive
▪ Enzyme-linked DAT
▪ Gel tests
▪ Flow cytometry
▪ Polybrene tests
• Positive DAT in a normal individual
– Healthy blood donors and hospitalized patients
▪ Positive DAT—No shortened RBC survival.
• Positive DAT in a normal individual
– Possible causes:
▪ Inefficient macrophage removal of sensitized RBCs
▪ Insufficient amount of Ab on the cell surface
▪ Subclass of Ab not recognized by macrophage
• Positive DAT in a normal individual
– Possible causes:
▪ The thermal amplitude of antibody (< 37°C)
▪ + DAT due to the presence of complement on RBCs
▪ Patients with hypergammaglobulinemia or receiving high-dose IV gamma globulin exhibit nonspecific binding.
Comments
Post a Comment